The Ministry of Health announced on January 30 that it has approved the use of Astra Zeneca COVID-19 vaccine for pandemic prevention and control in Vietnam.
Astra Zeneca COVID-19 vaccine is licensed in Vietnam. - Illustrative image (Photo: VNA)
Hanoi (VNA) – The Ministry of Health announced on January 30 that it has approved the use of Astra ZenecaCOVID-19 vaccine for pandemic prevention and control in Vietnam.
AstraZeneca COVID-19vaccine was co-invented by theUK’s University of Oxford and its spin-out company AstraZeneca. This vaccine is recommended for people aged between18 – 64.
This is the first COVID-19 vaccine licensed by the Ministry of Health for immunization to prevent COVID-19 caused by thecoronavirus SARS-CoV-2 in Vietnam.
According to Minister of Health Nguyen Thanh Long, Astra Zeneca pledged tosupply about 30 million doses of vaccine to Vietnam in 2021.
The ministry is working with other partners to increase the number of vaccinesfor Vietnam.
Astra Zeneca’s COVID-19 vaccine is expected to be available and injected into Vietnamesepeople in the first quarter of this year.
The ministry has also directed domestic vaccine producers to urgently conduct vaccineresearch, clinical trials and production.
The ministry said that Nanogen PharmaceuticalBiotechnology JSC (Nanogen) has completed the first phase of clinicaltrial of Nanocovax vaccine in the first phase, and it will carry out the secondphase of trial in early February.
Meanwhile, the Institute of Vaccines and Medical Biologicals (IVAC) in Nha Trang citybegan the first phase of trial for Covivax vaccine on January 21, andthe scheme is expected to be completed at the end of February./.
Vietnam will conduct the first phase of human trials of a locally made COVID-19 vaccine from December 10, Minister of Health Nguyen Thanh Long said at a meeting with Vietnamese vaccine producers on December 5.
The Institute of Vaccines and Medical Biologicals (IVAC), based in central Khanh Hoa province, has proposed the Ministry of Health allow human trials of its COVID-19 vaccine to begin in January, two months ahead of schedule.
A ceremony was held at the Hanoi Medical University on January 21 to kick-start clinical trials of COVIVAC, Vietnam’s second COVID-19 vaccine candidate and developed based on the new highly-infectious coronavirus variants.
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.
Astra Zeneca COVID-19 vaccine is licensed in Vietnam. - Illustrative image (Photo: VNA) 
